A multi-agent system approach for monitoring the prescription of restricted use antibiotics

L Godo1, J Puyol-Gruart, J Sabater

  • 1Artificial Intelligence Research Institute (IIIA), Spanish Council for Scientific Research (CSIC), Campus UAB, 08193 Bellaterra, Spain. godo@iiia.csic.es

Insights

This study introduces a multi-agent system to optimize hospital antibiotic use. The system helps pharmacists review restricted antibiotic prescriptions, suggesting cheaper, effective alternatives to reduce costs and improve patient care.

Area of Science:

  • Medical Informatics
  • Artificial Intelligence in Healthcare
  • Pharmacoeconomics

Background:

  • Hospitals utilize expensive antibiotics for restricted use (ARU) reserved for specific conditions.
  • Pharmacy departments routinely review ARU prescriptions to identify opportunities for cost savings and reduced patient harm.
  • Alternative, less aggressive, and more affordable antibiotics can often achieve similar therapeutic outcomes.

Purpose of the Study:

  • To develop and describe a multi-agent system (MAS) for assisting in the review of medical prescriptions involving antibiotics of restricted use.
  • To enhance the efficiency and accuracy of identifying cost-effective and therapeutically equivalent antibiotic alternatives.
  • To integrate a patient-centered MAS within a distributed hospital information system.

Main Methods:

  • A multi-agent system approach was designed, with individual agents assigned to each patient to monitor their therapy.
  • A dedicated pharmacy agent analyzes patient-specific data and prescribed ARU to suggest alternative treatments.
  • The system architecture was specified using the Electronic Institutions design methodology within a distributed hospital environment.

Main Results:

  • The proposed MAS facilitates the systematic review of restricted antibiotic prescriptions.
  • The system enables the identification of potential substitutions with cheaper and less aggressive antibiotic options.
  • The patient-centered agent design allows for personalized therapy assessment within a complex hospital IT infrastructure.

Conclusions:

  • The developed multi-agent system offers a valuable tool for hospital pharmacies to optimize the use of restricted antibiotics.
  • Implementing this system can lead to significant cost reductions and improved patient safety by promoting the use of appropriate and affordable treatments.
  • The Electronic Institutions framework provides a robust method for specifying complex, distributed agent-based systems in healthcare settings.

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...